MANILA, Philippines–A social media post has been making rounds claiming the Department of Health has officially announced the release of a “revolutionary” diabetes support product. These claims are not only misleading but could also pose a threat to public health. The post promotes “Glufarelin Gold” as a groundbreaking therapeutic product capable of normalizing glucose levels. “This new therapeutic product has the potential to return glucose levels to normal. ADVERTISEMENTEstablishments or entities distributing “Glufarelin Gold” without appropriate permissions are liable to face stringent regulatory actions and sanctions, according to the FDA.
